[Federal Register Volume 87, Number 41 (Wednesday, March 2, 2022)]
[Notices]
[Pages 11731-11732]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04324]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-967]


Bulk Manufacturer of Controlled Substances Application: Sterling 
Pharma USA, LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Sterling Pharma USA, LLC has applied to be registered as a 
bulk manufacturer of basic class(es) of controlled substance(s). Refer 
to Supplementary Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before May 2, 2022. 
Such persons may also file a written request for a hearing on the 
application on or before May 2, 2022.

ADDRESSES: The DEA requires that all comments be submitted 
electronically through the Federal eRulemaking Portal, which provides 
the ability to type short comments directly into the comment field on 
the web page or attach a file for lengthier comments. Please go to 
https://www.regulations.gov and follow the online instructions at that 
site for submitting comments. Upon submission of your comment, you will 
receive a Comment Tracking Number. Please be aware that submitted 
comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, 
your comment has been successfully submitted and there is no need to 
resubmit the same comment.''

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on January 12, 2022, Sterling Pharma USA, LLC, 1001 
Sheldon Drive, Suite 101, Cary, North Carolina 27513-2078, applied to 
be registered as a bulk manufacturer of the following basic class(es) 
of controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols...................    7370  I
------------------------------------------------------------------------

    In reference to drug codes 7370 (Tetrahydrocannabinols), the 
company plans to bulk manufacture this drug exclusively from hemp 
extract for distribution and sale to its customer. No

[[Page 11732]]

other activities for these drug codes are authorized for this 
registration.

Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022-04324 Filed 3-1-22; 8:45 am]
BILLING CODE P